Retinal Insider

Targeting VEGF’s Silent Partners in DME

A look at what’s going on behind the scenes in patients for whom anti-VEGF therapy has little or no effect.
08/05/2016

Identifying the Pachychoroid Phenotype

Sub-segmenting the choroid using novel imaging modalities may lead to a better understanding of macular diseases.
07/05/2016

Complement Inhibition For the Treatment of GA

Large-scale studies support the role of aberrant activation of the alternative complement pathway in AMD pathophysiology.
06/05/2016

CMV Retinitis: Reduced Incidence, Still a Threat

Cytomegalovirus retinitis is a sight-threatening infection caused by a member of the human herpesviridae family.
05/10/2016

Ultra-Widefield Retinal Imaging in Uveitis

Advances in imaging have led to improved quantitative and qualitative assessment of uveitis-related pathology.
04/05/2016

Spectral-Domain OCT in Managing Uveitis

Advances in imaging have led to improved quantitative and qualitative assessment of uveitis-related pathology.
03/04/2016

Real-World Utilization of Anti-VEGF Agents

How ‘real world’ clinical experience with anti-VEGF drugs in treating three FDA-approved indications differs from clinical trial results.
02/05/2016

A New Understanding of Vitreous Structure

Advances in imaging technologies are changing both the way we think of the vitreous and how we treat patients.
01/05/2016

Shifting Focus in Retinal Implant Development

Moving beyond the proof-of-concept stage, a greater emphasis on the functional outcomes of retinal implants is needed.
12/08/2015

Personalized Medicine: Impact on Retina Therapies

The power of genetically defined targets in the development of retinal therapies is beginning to bear fruit. Where it’s headed next.
11/05/2015